Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Shrink-Wrap Technology Helps Enhance Detection of Biomarkers

By LabMedica International staff writers
Posted on 02 Apr 2014
A novel technique uses wrinkles in metal-coated shrink-wrap to boost fluorescent signals 1,000-fold. More...
The new technology may pave the way for low-cost, highly sensitive biomarker detection and diagnostic devices, and for enabling clinics in resource-limited regions provide their communities with more sensitive detection of infectious diseases.

A persistent challenge in fluorescence detection is to increase the signal to noise ratio of weakly fluorescent biomarkers or of biomolecules present at low concentration. Also, current methods for detection of infectious disease agents are predominantly cost-prohibitive in most areas of the world. Now a novel nanotechnology method using common shrink-wrap may help solve both problems.

The new technology, described by H. Sharma et al. in the Optical Society’s (Washington DC, USA) journal Optical Materials Express, on March 20, 2014, offers a way to significantly boost the signal of fluorescent markers used in biosensing by depositing a combination of metals onto shrink-wrap. “Using commodity shrink-wrap and bulk manufacturing processes, we can make low-cost nanostructures to enable fluorescence enhancements greater than a 1,000-fold, allowing for significantly lower limits of detection,” said Michelle Khine, biomedical engineering professor at the University of California, Irvine (USA); “If you have a solution with very few molecules that you are trying to detect—as in the case of infectious diseases—this platform will help amplify the signal so that a single molecule can be detected.”

In the method, developed by the UC Irvine team led by Prof. Khine, thin layers of gold and nickel are first deposited onto a prestressed thermoplastic polymer (shrink-wrap film). When heated, the shrink-wrap contracts, causing the stiffer metal layers to buckle and wrinkle into flower-like structures that are significantly smaller than previously achieved. Fluorescent-probe tagged biomarkers are added onto the wrinkled metal layer. Specifically, they observed more than three orders of magnitude enhancement in the fluorescence signal emitted from a single molecule of goat anti-mouse immunoglobulin G (IgG) antibody tagged with fluorescein isothiocyanate, FITC, (FITC-IgG), by two-photon excitation.

The enhanced emission is due to the excitation of localized surface plasmons (coherent oscillations of the free electrons in the metal). When light was shined onto the wrinkled surface, the electromagnetic field was amplified within the nanogaps between the shrink-wrap folds. This produced “hotspot” areas characterized by sudden bursts of intense fluorescence signals from the biomarkers. This is the first demonstration of leveraging the plasmons in such hybrid nanostructures by metal enhanced fluorescence (MEF) in the near-infrared wavelengths. The structures can be tuned to have a diverse range of architectures and nanogap sizes with tunable plasmon resonances, to achieve large fluorescence enhancements in other regions of the excitation wavelength spectrum.

Though the current setup requires expensive equipment, the team believes this approach will pave the way to creating an integrated, low-cost device to magnetically trap and sensitively detect labeled molecules and nanoparticles. However, biological sample testing is itself another technical challenge: “The technique should work with measuring fluorescent markers in biological samples, but we have not yet tested bodily fluids,” said Prof. Khine, who cautions that the technique is far from ready for clinical use. For example, she notes, “We are currently working on trying to detect Rotavirus, but one of the main challenges is that our surface is hydrophobic so diffusion of the biomarker onto our composite structures is limited."

University of California, Irvine
The Optical Society

Related Links:

New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.